Details for New Drug Application (NDA): 201802
✉ Email this page to a colleague
The generic ingredient in EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE is efavirenz; emtricitabine; tenofovir disoproxil fumarate. There are twenty-six drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the efavirenz; emtricitabine; tenofovir disoproxil fumarate profile page.
Summary for 201802
Tradename: | EFAVIRENZ; EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE |
Applicant: | Strides Pharma |
Ingredient: | efavirenz; emtricitabine; tenofovir disoproxil fumarate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 600MG;200MG;300MG | ||||
Approval Date: | Oct 3, 2023 | TE: | RLD: | No |
Complete Access Available with Subscription